Compare AVX & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVX | LONA |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | Canada | United States |
| Employees | 3 | 26 |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.3M | 53.4M |
| IPO Year | N/A | N/A |
| Metric | AVX | LONA |
|---|---|---|
| Price | $0.54 | $9.43 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 288.4K | 76.8K |
| Earning Date | 05-14-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $530,767.50 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $4.21 |
| 52 Week High | $2.27 | $14.21 |
| Indicator | AVX | LONA |
|---|---|---|
| Relative Strength Index (RSI) | 31.01 | 59.47 |
| Support Level | N/A | $4.52 |
| Resistance Level | $0.84 | $14.21 |
| Average True Range (ATR) | 0.06 | 1.74 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 1.40 | 38.08 |
AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.
LeonaBio Inc is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).